Facebook Linkedin RSS Twitter Youtube
Home 2024

Janssen Pharmaceuticals

StockWatch: Biogen Q1 Results Beat Expectations, for a Change
Drug Discovery

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M
Drug Discovery

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
Drug Discovery

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Ensuring the Purity of Gene Therapy Products and Vaccines
Drug Discovery

Ensuring the Purity of Gene Therapy Products and Vaccines

Jabbing at Alzheimer’s: AC Immune Takes Precision Approach to Vaccines
Drug Discovery

Jabbing at Alzheimer’s: AC Immune Takes Precision Approach to Vaccines

Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell Therapy
Drug Discovery

Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell Therapy

Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration
GEN Edge

Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration

Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists

Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021

HIV Vaccine Disappointment: Trial Data Show Lack of Sufficient Protection
Drug Discovery

HIV Vaccine Disappointment: Trial Data Show Lack of Sufficient Protection

AGTC Proves a Durable Competitor in Gene Therapy for X-Linked Retinitis Pigmentosa
Drug Discovery

AGTC Proves a Durable Competitor in Gene Therapy for X-Linked Retinitis Pigmentosa

123...14Page 1 of 14
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.